Assignee
NANJING ANJI BIOLOGICAL TECH CO LTD
CN·7 granted patents·5 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
12 records- 0157US12404301B2Polypeptide having anti-aging activity, and application thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·5 claims
- 0256US12286461B2Recombinant fused polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Apr 29, 2025·0 cites·9 claims
- 0356US2024247079A1Anti-hmmw antibody, composition comprising same, and nucleic acid molecule encoding same, and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0449US12404303B2Polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Sep 2, 2025·0 cites·5 claims
- 0549US12398196B2Fused polypeptide with multifunctional activities and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Granted Aug 26, 2025·0 cites·7 claims
- 0648US2024076313A1Polypeptides rv3 and rv4 having anti-aging function and applications thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0746US11192921B2Polypeptide having analgesic activity and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2018·Granted Dec 7, 2021·0 cites·5 claims
- 0846US2022332763A1Fused polypeptide and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 0942US10869931B2Polyethylene glycol-modified angiogenesis inhibitor HM-1 and application thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2017·Granted Dec 22, 2020·0 cites·6 claims
- 1040US11932872B2Dual chimeric antigen receptor-t cell which can be regulated, construction method therefor and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2018·Granted Mar 19, 2024·0 cites·3 claims
- 1136US2019031717A1Multi-functional fusion polypeptide, preparation method thereof, and application of sameNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2017·Application pending·0 cites
- 1233US2020270309A1Maleimide group-modified angiogenesis inhibitor hm-1 and use thereofNANJING ANJI BIOLOGICAL TECH CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING ANJI BIOLOGICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →